• Explore /
  • Poster
  • / Phase II study of bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater.

Phase II study of bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater.

Abstract Poster

Authors

null

Pat Gulhati

The University of Texas MD Anderson Cancer Center, Houston, TX

Pat Gulhati , Kanwal Pratap Singh Raghav , Rachna T. Shroff , Gauri R. Varadhachary , Scott Kopetz , Milind M. Javle , Wei Qiao , Huamin Wang , Jeffrey Morris , Robert A. Wolff , Michael J. Overman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 144)

DOI

10.1200/jco.2016.34.4_suppl.144

Abstract #

144

Poster Bd #

M14

Abstract Disclosures

Similar Posters

First Author: Min-Young Lee

First Author: Ilya Tsimafeyeu

First Author: Shunsuke Tsukamoto

First Author: Xin Qu